@article{article, title  = {{Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Springer Verlag}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/130271 }},

 year = {{2018}},

 month = {{10}},

 author = {{Rafia R and Pandor A and Davis S and Stevens JW and Harnan S and Clowes M and Sorour Y and Cutting R}},

 doi = {{10.1007/s40273-018-0645-2}},

 volume = {{36}},

 journal = {{Pharmacoeconomics}},

 issue = {{10}},

 pages = {{1143-1151}},

 note = {{Accessed on 2025/10/31}}}